Postreading Self-Assessment and CME Test
Postreading Self-Assessment and CME Test
Postreading Self-Assessment and CME Test
SELF-ASSESSMENT
AND CME
Self-Assessment
and CME Test
By D. Joanne Lynn, MD, FAAN; James W. M. Owens Jr, MD, PhD
SLEEP NEUROLOGY
The Continuum Postreading Self-Assessment and CME Test is an integral
part of the issue that is intended to stimulate thought and help participants
assess general understanding of the material presented in this issue. The
Postreading Self-Assessment and CME Test is also approved by the
American Board of Psychiatry and Neurology (ABPN) to meet the Lifelong
Learning (CME), Self-Assessment (SA) (part 2) component for Continuing
Certification (CC).
For each item, select the single best response. A tally sheet is provided
with this issue to allow the option of marking answers before entering them
online at continpub.com/CME. Nonsubscribers who have purchased single
back issues should email ContinuumCME@aan.com for instructions to
complete this test online.
CONTINUUMJOURNAL.COM 1085
A cholinergic
B dopaminergic
C glutamatergic
D histaminergic
E serotonergic
A dorsal raphe
B lateral dorsal tegmental
C locus coeruleus
D parabrachial
E pedunculopontine
A adenosine
B cortisol
C dopamine
D hypocretin
E melatonin
A history of adenotonsillectomy
B macroglossia
C neck circumference of 38 cm (15 in) in a man
D orthostatic hypotension
E prognathia
A brain MRI
B EEG
C home sleep apnea test
D maintenance of wakefulness test
E multiple sleep latency test
CONTINUUMJOURNAL.COM 1087
A cataplexy
B daytime sleep attacks
C disrupted nocturnal sleep
D sleep paralysis
E sleep-related hallucinations
A lithium
B methylphenidate
C pitolisant
D sodium oxybate
E solriamfetol
A chronic insomnia
B idiopathic hypersomnia
C insufficient sleep syndrome
D Kleine-Levin syndrome
E narcolepsy type 1
13 Women with obstructive sleep apnea are more likely to present with
which of the following symptoms compared with men with a similar
severity of disease?
A apneas
B delirium
C gasping
D insomnia
E snoring
A fissuring
B geographic tongue
C leukoplakia
D lichen planus
E scalloping
CONTINUUMJOURNAL.COM 1089
A adenotonsillectomy
B implantation of a phrenic nerve stimulator
C implantation of an upper airway stimulator
D mandibular advancement
E uvulopalatopharyngoplasty
17 People with rapid eye movement (REM) sleep behavior disorder are
at the highest risk of developing which of the following
neurodegenerative diseases?
A Alzheimer disease
B amyotrophic lateral sclerosis
C corticobasal degeneration
D dementia with Lewy bodies
E Huntington disease
A alprazolam
B baclofen
C donepezil
D gabapentin
E melatonin
A absence of hallucinations
B fewer motor fluctuations
C indolent less aggressive course
D less autonomic instability
E non–tremor-predominant presentation
A confusional arousals
B nightmares
C nocturnal panic attacks
D rapid eye movement (REM) sleep behavior disorder
E sleep terrors
A clonazepam
B haloperidol
C sodium oxybate
D trazodone
E zolpidem
CONTINUUMJOURNAL.COM 1091
23 A 6-year-old boy has nightly episodes that are stereotyped and brief,
usually lasting less than 60 seconds. His parents first noted something
was amiss when he began to wet the bed again after a year of being dry
at night. The parents moved him to their bed so they could monitor the
episodes. The episodes occur at any time of night and begin with a
moan and brief stiffening followed by shaking of his limbs, during
which enuresis occurs. This is followed by a brief arousal and return to
sleep. The patient does not recall anything specific about the nocturnal
events but does remember that “he had one.” Given this description,
which of the following types of nocturnal events is most likely?
A confusional arousal
B rapid eye movement (REM) sleep behavior disorder
C rhythmic movement disorder
D seizure
E sleep terror
A begin clonazepam
B begin pramipexole
C stop metoclopramide
D stop zolpidem
E switch lisinopril for another antihypertensive
A clonazepam
B gabapentin
C IV iron
D oral iron supplementation
E pramipexole
A clonazepam
B gabapentin
C iron
D levodopa
E pramipexole
CONTINUUMJOURNAL.COM 1093
A caffeine
B lemborexant
C melatonin
D modafinil
E tasimelteon
A arcuate
B dorsomedial
C preoptic
D suprachiasmatic
E tuberomammillary
ARTICLE 9: INSOMNIA
A bioenergy therapy
B cognitive-behavioral therapy
C energetic sleep hygiene
D melatonin
E zolpidem
A acupuncture
B autonomous meridian sensory response
C hypnotherapy
D Reiki
E therapeutic touch
A lateral hypothalamus
B midbrain reticular formation
C nucleus accumbens
D suprachiasmatic nuclei
E ventral medial hypothalamus
A history of smoking
B hypertension
C hyposmia
D negative family history for movement disorders
E younger age
CONTINUUMJOURNAL.COM 1095
A dystonia
B essential tremor
C Huntington disease
D Parkinson disease
E tardive dyskinesia
A adverse effect
B allergy
C behavioral disorder
D paradoxical reaction
E pharmacogenomic trait
A chronic insomnia
B idiopathic hypersomnia
C insufficient sleep syndrome
D restless legs syndrome
E restless sleep disorder
A baclofen
B clonazepam
C fluoxetine
D gabapentin
E sodium oxybate
CONTINUUMJOURNAL.COM 1097